Siru P Mäkelä

4PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 10, 2020
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients.

Henna Kasanen, Micaela Hernberg, Siru Mäkelä

|Feb 01, 2020
Limited-duration anti-PD-1 therapy for patients with metastatic melanoma.

Siru Mäkelä, Laura Kohtamäki, Marjut Laukka

Pageof 1